These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29715146)

  • 1. A Genitourinary Cancer-specific Scoring System for the Prediction of Survival in Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Owari T; Miyake M; Nakai Y; Morizawa Y; Hori S; Anai S; Tanaka N; Fujimoto K
    Anticancer Res; 2018 May; 38(5):3097-3103. PubMed ID: 29715146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features and Risk Factors of Skeletal-Related Events in Genitourinary Cancer Patients with Bone Metastasis: A Retrospective Analysis of Prostate Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma.
    Owari T; Miyake M; Nakai Y; Morizawa Y; Itami Y; Hori S; Anai S; Tanaka N; Fujimoto K
    Oncology; 2018; 95(3):170-178. PubMed ID: 29874673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of early treatment with bone-modifying agents for preventing skeletal-related events in patients with genitourinary cancer with bone metastasis: A multi-institutional retrospective study.
    Owari T; Miyake M; Nakai Y; Hori S; Tomizawa M; Ichikawa K; Shimizu T; Iida K; Samma S; Iemura Y; Momose H; Omori C; Otani T; Kuwada M; Hirao S; Oyama N; Nakagawa Y; Hayashi Y; Tanaka N; Fujimoto K
    Int J Urol; 2019 Jun; 26(6):630-637. PubMed ID: 30883931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic classification of patients with metastatic renal cell carcinoma of bone.
    Toyoda Y; Shinohara N; Harabayashi T; Abe T; Akino T; Sazawa A; Nonomura K
    Eur Urol; 2007 Jul; 52(1):163-8. PubMed ID: 17098353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Salah S; Lee JL; Rozzi A; Kitamura H; Matsumoto K; Srinivas S; Morales-Barrera R; Carles J; Al-Wardat R; Al-Rabi K; Maakoseh M
    Clin Genitourin Cancer; 2016 Jun; 14(3):255-60. PubMed ID: 26552764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional study.
    Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Kawai T; Tanaka Y; Yoshida K; Yamamoto S; Enomoto Y; Nose Y; Sato T; Ishikawa A; Uemura Y; Fujimura T; Fukuhara H; Kume H; Homma Y
    Int J Urol; 2015 Jul; 22(7):638-43. PubMed ID: 25903328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Tsuda Y; Nakagawa T; Shinoda Y; Kanatani A; Kawai T; Taguchi S; Yamada Y; Sawada R; Kume H; Homma Y; Tanaka S; Kawano H
    Int J Clin Oncol; 2017 Jun; 22(3):548-553. PubMed ID: 28044212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of multimodal treatment on prognosis for patients with metastatic upper urinary tract urothelial cancer: Subanalysis of the multi-institutional nationwide case series study of the Japanese Urological Association.
    Inokuchi J; Naito S; Fujimoto H; Hara T; Sakura M; Nishiyama H; Miyazaki J; Kikuchi E; Hinotsu S; Koie T; Ohyama C;
    Int J Urol; 2016 Mar; 23(3):224-30. PubMed ID: 26659912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prediction model of survival for patients with bone metastasis from uterine cervical cancer.
    Matsumiya H; Todo Y; Okamoto K; Takeshita S; Yamazaki H; Yamashiro K; Kato H
    J Gynecol Oncol; 2016 Nov; 27(6):e55. PubMed ID: 27550401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External validation of a genitourinary cancer-specific prognostic scoring system to predict survival for patients with bone metastasis (modified B-FOM scoring model): Comparison with other scoring models in terms of accuracy.
    Owari T; Miyake M; Nakai Y; Tanaka N; Itami Y; Hirao S; Momose H; Nakagawa Y; Iida K; Maesaka F; Shimizu T; Iemura Y; Matsumoto Y; Kuwada M; Otani T; Otsuka K; Okajima E; Hosokawa Y; Okamura R; Fujimoto K
    J Bone Oncol; 2021 Feb; 26():100344. PubMed ID: 33384916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival.
    Li G; Yu J; Song H; Zhu S; Sun L; Shang Z; Niu Y
    BMC Cancer; 2017 Aug; 17(1):530. PubMed ID: 28789622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model.
    Gravis G; Boher JM; Fizazi K; Joly F; Priou F; Marino P; Latorzeff I; Delva R; Krakowski I; Laguerre B; Walz J; Rolland F; Théodore C; Deplanque G; Ferrero JM; Pouessel D; Mourey L; Beuzeboc P; Zanetta S; Habibian M; Berdah JF; Dauba J; Baciuchka M; Platini C; Linassier C; Labourey JL; Machiels JP; El Kouri C; Ravaud A; Suc E; Eymard JC; Hasbini A; Bousquet G; Soulie M; Oudard S
    Eur Urol; 2015 Aug; 68(2):196-204. PubMed ID: 25277272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone metastases in patients with metastatic renal cell carcinoma: are they always associated with poor prognosis?
    Santoni M; Conti A; Procopio G; Porta C; Ibrahim T; Barni S; Guida FM; Fontana A; Berruti A; Berardi R; Massari F; Vincenzi B; Ortega C; Ottaviani D; Carteni G; Lanzetta G; De Lisi D; Silvestris N; Satolli MA; Collovà E; Russo A; Badalamenti G; Luzi Fedeli S; Tanca FM; Adamo V; Maiello E; Sabbatini R; Felici A; Cinieri S; Montironi R; Bracarda S; Tonini G; Cascinu S; Santini D
    J Exp Clin Cancer Res; 2015 Feb; 34(1):10. PubMed ID: 25651794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
    Mackey JR; Au HJ; Hugh J; Venner P
    J Urol; 1998 May; 159(5):1624-9. PubMed ID: 9554367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and prognostic factors of patients with renal cell cancer with bone metastasis in the era of targeted therapy: A single-institution analysis.
    Du Y; Pahernik S; Hadaschik B; Teber D; Duensing S; Jäger D; Hohenfellner M; Grüllich C
    Urol Oncol; 2016 Oct; 34(10):433.e1-8. PubMed ID: 27321354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and survival of renal clear cell carcinoma patients with bone metastases.
    Szendroi A; Dinya E; Kardos M; Szász AM; Németh Z; Ats K; Kiss J; Antal I; Romics I; Szendroi M
    Pathol Oncol Res; 2010 Mar; 16(1):29-38. PubMed ID: 19639393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of bone complications in patients with genitourinary malignancies.
    Ballon-Landa E; Panian J; Derweesh IH; McKay RR
    Urol Oncol; 2020 Mar; 38(3):94-104. PubMed ID: 31676279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
    Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
    BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.